Nanjing Chia-tai Tianqing Pharmaceutical clinical trials
A subsidiary of Sino Biopharmaceutical Limited
The registry lists 18 studies whose lead sponsor is Nanjing Chia-tai Tianqing Pharmaceutical. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 10, 2026.
Status
Where
- China
- 13
Registry sponsor names on this page
- Nanjing Chia-tai Tianqing Pharmaceutical18 studies
Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.
Studies
Recruiting first, then most recently updated. Showing 18 of 18. All Sino Biopharmaceutical Limited studies →
- An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)Not yet recruitingNCT07462130Phase 1/2
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast CancerNot yet recruitingNCT07393321Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy ParticipantsEnrolling by invitationNCT07182552Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsNot yet recruitingNCT07177859Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Long-term Efficacy and Safety of NTQ5082 CapsulesNot yet recruitingNCT07177872Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA NephropathyNot yet recruitingNCT06982040Phase 2
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Clinical Study on the Effectiveness and Safety of Succinylated Gelatin InjectionNot yet recruitingNCT06977763Not applicable
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate InjectionRecruitingNCT06977750Not applicable
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Effect of Food of NTQ5082 in Healthy SubjectsNot yet recruitingNCT06558656Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase 1 Clinical Trial of NTQ5082 in Healthy VolunteersNot yet recruitingNCT06560593Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Study of Ramelteon in Chinese Patients With Chronic InsomniaNot yet recruitingNCT06512363Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast CancerRecruitingNCT06172322Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological MalignanciesRecruitingNCT06049667Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated PainCompletedNCT06076486Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsActive, not recruitingNCT06764303Phase 2
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid TumorsCompletedNCT06172309Phase 1
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary CholangitisCompletedNCT05450887Phase 3
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical
- Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver MetastasesStatus unknownNCT01959061Phase 4
Sponsor listed in the registry: Nanjing Chia-tai Tianqing Pharmaceutical